LSLiliya V. Selezneva

Liliya V. Selezneva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Liliya V. Selezneva has a total of 55 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Modern possibilities for treating acute rhinosinusitis using herbal medications

    by Valery M. Svistushkin, Liliya V. Selezneva, Mikhail V. Svistushkin, Gaya V. Lebedeva, Igor A. Zinchenko

    Aspects of the clinical use of herbal preparations for acute rhinosinusitis (ARS) are considered, in the pathogenesis of which swelling of the mucous membrane of the nasal cavity and paranasal sinuses plays a key role. The irrational use of antibacterial drugs for the treatment of uncomplicated ARS has led to the emergence of antibiotic-resistant strains of bacteria and the need to search for alternative treatment methods. Convincing evidence is presented for the need to use herbal medicines in both complex and monotherapy of ARS of viral and bacterial origin. This review assessed the quality of the evidence for the use of herbal medicine for acute rhinosinusitis to determine its position among other treatments and future directions for research. Clinical studies of the effectiveness of the drug Sinupret extract are presented, the use of which promotes the outflow of exudate from the paranasal sinuses and upper respiratory tract, preventing the development of complications.


  • Open Access

    Mesenchymal stromal cells based bioengineered implants in vocal folds and tympanic membrane restoration (рilot experimental results)

    by M. V. Svistushkin, A. A. Bakulina, P. Yu. Bikmulina, A. V. Zolotova, L. V. Selezneva, E. A. Shevchik, P. A. Kochetkov, N. B. Serejnikova, A. N. Nikiforova, I. A. Tychkina, et al.

    Introduction. One of the most pressing issues of modern otorhinolaryngology is the problem of the formation of persistent defects of the vocal cords and tympanic membrane. This state of affairs is due to the variety of reasons that cause the development of these conditions, as well as the fact that the treatment of these processes, as a rule, is a technically complex task and is not always effective.Aim. Experimental evaluation of the possibility of using bioengineered implants based on MSCs, PEG-fibrin gel and collagen matrix to restore defects in vibrating tissues of ENT organs – vocal folds and tympanic membrane.Materials and methods. For the experiment on vocal fold restoration, 6 rabbits were selected, divided equally into 2 groups. After the formation of the vocal fold scar, a bioequivalent was implanted: spheroids based on MSCs + PEG-fibrin gel (group – VF-spheroids, n = 3) in a volume of 0.5 ml, for the control group, the role of bioequivalent was performed by saline solution (VF-control group, n = 3). For the eardrum repair experiment, 6 chinchillas were selected, divided equally into 2 groups. At the first stage, a persistent chronic perforation was created, on which either no intervention was carried out (ED-control group, n = 3), or the perforation was closed using a bioequivalent based on MSC spheroids, PEG-fibrin gel and collagen matrix (ED-spheroid group, n = 3).Results and discussion. Endoscopic and morphological examination revealed a more complete restoration of tissue structure in the treatment groups compared to the control groups.Conclusion. Implantation of the developed bioequivalents in the sites of vocal fold and tympanic membrane injury leads to the formation of tissue morphologically similar to the structure of intact structures.

  • Development and validation of Russian olfactory test

    by G.V. Lebedeva, M.V. Svistushkin, L.V. Selezneva, Yu.N. Muzychenko, A.YU. Suvorov, I.V. Khutornoi, A.V. Pedder, V.V. Pedder, V.A. Kudryavtseva, K.K. Pogosyan

    Olfactory disorders is one of the first symptoms of diseases from various departments of medicine (otorhinolaryngology, psychology, neurology, etc.). Based on international clinical recommendations, olfactory tests are the gold standard for the diagnosis of olfactory disorders. There are many different psychophysical tests: UPSIT (USA, Pennsylvania), Sniffin’ Sticks test (Germany), BAST-24 (Spain), etc. Currently, there is an acute shortage of olfactory tests available for clinical practice In Russia. This problem is related to the fact that there are no olfactory tests registered as medical devices on the territory of the Russian Federation. Also, a significant limitation is the unrecognizability of odors by the population of our country, which include foreign analogues (licorice, anise, turpentine, etc.). Objective. To develop and validate the national olfactory test on healthy volunteers. Material and methods. The development and validation of the olfactory test included several stages. First, the development of an olfactory test was carried out, the selection of aromas to assess the threshold and identification ability of olfaction. 25 dilutions of n-butanol were used for the assessment of the threshold olfactory ability. For the stage of assessing the identification ability of the sense of smell, in our previous study, an assessment of the recognition of odor names in the territory of the Russian Federation was carried out. A total of 3.000 people from 8 federal districts of the Russian Federation were interviewed. During the development of the test, 20 names of flavors with the highest rating were used. By the 8th, the selection of monocomponent substances was carried out. Commercially available certified food and perfume flavorings have been used for fragrances whose equivalent in the test cannot be a monocomponent substance. A group of 25 healthy volunteers selected a flavor or a monocomponent for each of the 20 positions. To carry out the identification stage of testing, a booklet was developed with answer options for each fragrance, including 80 images associated with the smell. A methodology for conducting diagnostics has been created. Next, the validation of the developed olfactory test was carried out on 150 healthy volunteers. The study included an assessment of the threshold and identification ability of the sense of smell using the developed test and conducting a comparative analysis with a set of flavors and descriptors corresponding to the Sniffin’ Sticks test. Results. The developed test includes: 2 panels — panel 1 to assess the threshold ability of smell, panel 2 to assess the identification ability of smell, a booklet with 80 images and captions to them. The norms of threshold and identification olfactory abilities were also determined in the developed test. The domestic test was validated against the relative foreign Sniffin’ Sticks test. Spearman’s correlation between the accuracy values of the domestic test (17—20; 85.00—100.00%) and the values of the foreign test (11—16; 68.75—100.00%) did not reveal statistically significant differences (rs=0.065, p=0.432), which confirms the equally effective assessment of olfactory ability by the domestic olfactory test in comparison with its foreign counterpart. Conclusion. In this work, a methodology for the use of Russian olfactory test was developed and validated on healthy volunteers. The features of the developed test are an assessment of the threshold and identification ability of smell, an adapted set of odors for the Russian population, the use of paper blotters when applying flavor and visual images of descriptors. Despite the wide variety of psychophysical tests, this problem requires further study and comparative analysis of olfactory tests available In Russia and foreign analogues in order to obtain a universal and effective diagnostic method for the populations of our country. This work was supported by the Russian Foundation for Basic Research (Project No. 24-25-00415).


  • Open Access

    Odors determition among the population of the regions of the Russian Federation: Cross-sectional study

    by G. V. Lebedeva, M. V. Svistushkin, L. V. Selezneva, E. V. Alekseenko, I. A. Kirsch, S. V. Morozova, V. M. Svistushkin

    Introduction. Currently, the main way to assess olfactory disorders is olfactory tests. A necessary condition for adequate diagnosis is that the odors used in tests correspond to the sociocultural characteristics of the population; the identified flavors must be well recognizable. The use of unadapted tests distorts the results and leads to a false diagnosis of the pathology in a person with a normal sense of smell. The research for identification of the most known odors is an important stage in validation of the existing tests and in the development of new ones.Aim. Determination odors in various regions of the Russian Federation.Materials and methods: 3000 people from 8 federal districts of the Russian Federation took part in the study. This study was conducted using a questionnaire based on a Likert scale. The subject was required to assess his level of familiarity with each odor from the proposed list, assigning it a score from 1 to 5. In total, the questionnaire listed 100 names, including 16 names of odors, the standard set of the 3rd stage (assessment of identification ability) Sniffin’ Sticks Test, 40 names of odorants of the University of Pennsylvania Psychophysical Test (UPSIT) and 44 odors found in the everyday life of the population of our country.Results. In the first 25 positions of the most recognizable smells, in descending order, there are: 1) coffee; 2) orange; 3) garlic; bleach; 5) mint; 6) tobacco smoke; 7) gasoline; 8) tangerine; 9) lemon; 10) smoke from a fire; 11) onion; 12) strawberry; 13) apple; 14) alcohol; 15) fish; 16) mown grass; 17) chocolate; 18) acetone; 19) banana; 20) hot bread; 21) rose; 22) lilac; 23) melon; 24) watermelon; 25) cucumber. Among the 16 odors of the 3rd stage of identification of the standard set “Sniffin’ Sticks Test” – 43.75% are included in the first 16 positions of recognizable odors of the Russian rating, and among the 40 odors of the UPSIT olfactory test – 52.5%.Conclusions: This study showed which odors are well recognized by the Russian population and confirmed that cultural adaptation as a necessary procedure before routine use of olfactory tests.


  • Open Access

    Using of herbal mucolytics in the complex therapy of acute and chronic rhinosinusitis

    by L. V. Selezneva, K. G. Vartanyan

    Chronic rhinosinusitis is a polyetiological heterogeneous disease that is characterized by inflammation of the nasal mucosa and paranasal sinuses. The clinical picture of this pathology may include nasal congestion and rhinorrhea. Studies on the pathogenesis of chronic rhinosinusitis have yielded insufficient results, however, a number of factors that predispose to the development of this disease are currently identified according to clinical guidelines. Among these are both anatomical anomalies and some chronic diseases (rhinitis, atopy), immune system disorders (immunodeficiencies), etc. Mucoactive drugs are used in the treatment of acute and chronic rhinosinusitis to restore the transport function of the upper respiratory tract epithelium. Their mechanism of action is aimed at restoring mucociliary clearance. This therapy also affects the viscous discharge, which is produced during rhinosinusitis and accumulates in the paranasal sinuses and nasal cavity, worsening the course of the inflammatory process. Specialists distinguish the following forms of mucoactive drugs: mucolytics, mucokinetics and mucoregulators. The article considers the aspects of the clinical use of herbal mucolytics for the treatment of acute and chronic rhinosinusitis, in the pathogenesis of which the nasal mucosa edema plays a key role. The authors summarise the most conclusive evidence to date on the need to use herbal mucolytics in the complex therapy of acute and chronic rhinosinusitis. The modern topical therapy of acute and chronic rhinosinusitis in the otorhinolaryngology practice is presented. Herbal medicinal products have a proven secretolytic and anti-inflammatory effect, accelerate the relief of symptoms and reduce the recovery time of patients. The clinical guidelines recommend to prescribe these drugs in addition to the complex therapy of rhinosinusitis to patients suffering from ARS and CRS, who has no contraindications.


  • Open Access

    Modern methods of diagnosis and treatment of patients with COVID and post-COVID anosmia

    by G. V. Lebedeva, S. V. Morozova, L. V. Selezneva, M. V. Svistushkin

    Since 2019, the interest in coronavirus infection has increased worldwide due to the emergence of several pandemic outbreaks associated with this group of pathogens. In total, 3 outbreaks of pandemics were registered in the 21st century, caused by new strains of coronaviruses: MERS-CoV, SARS-CoV and SARS-CoV-2. Among them the leader in prevalence, occurrence of severe respiratory complications and mortality is SARS-CoV-2. SARS-CoV-2 is the causative agent of the coronavirus disease of 2019. COVID-19 is a disease characterized by acute respiratory viral syndrome, transmitted by airborne droplets. The clinical course of COVID-19 varies significantly from patient to patient and can range from asymptomatic to severe forms. One of the common symptoms of the manifestation of COVID-19 is a smell disorder. The pathogenesis and clinical course of coronavirus infection caused by SARS-CoV-2 were examined to identify the causes leading to olfactory disorders in the manuscript. The analysis of existing methods for the diagnosis of olfactory disorders and their treatment was also carried out. The content of the article includes current hypotheses of the pathogenesis of viral anosmia in COVID-19 and a new look at the relevance of this problem among the population around the world. The article analyzes scientific data on the problem of anosmia in coronavirus infection caused by SARS-CoV-2, investigates modern diagnostic methods, highlights the principles of treatment of patients with post-COVID anosmia and presents prospects for further research on this problem.

  • Open Access

    A New Method for Plastic Closure of an Extensive Laryngotracheal Defect.

    by Liliya V. Selezneva, Svetlana V. Starostina, Alexey V. Toldanov, Emil N. Sobol, Olga I. Baum, Valeriy M. Svistushkin

    Elimination of extensive defects of the larynx and trachea by using musculoskeletal plastics without the use of supporting materials is not always sufficient. Laser modeling of cartilage tissue is a promising technique in modern medicine. This article presents a new method for plastic closure of an extensive defect in the larynx and trachea with the help of costal auto-cartilage modeled by an erbium fiber laser with wavelength of 1.56 μm. The presented method allows us to restore the anatomical integrity of the respiratory tract at the final stage of surgical treatment of patients with chronic combined laryngeal and tracheal stenosis. Presented own clinical observation.

  • Open Access

    Possibilities of using multidirectional immunomodulators for acute and recurrent infectious and inflammatory diseases of the upper respiratory tract

    by S. V. Morozova, L. V. Selezneva

    In many countries, with the prevention of acute respiratory diseases in children and adults, the use of various types of biologically active substances of natural and synthetic origin, called immunostimulants of various mechanisms of action, has been introduced. The purpose of this article is to provide a useful overview of main roles of available immunostimulants and their potential for use in inflammatory diseases of the upper respiratory tract. The article discusses aspects of the clinical use of immunomodulatory drugs in acute and recurrent infectious and inflammatory diseases of the respiratory tract (SARS-CoV-2 included). The mechanisms of action of immunomodulators on the immune system are briefly outlined. On the drug Imunorix the evidence base of mechanisms of correction of the immune system in respiratory diseases of the upper respiratory tract is given, as well as the analysis of the clinical efficacy of drug. The use of immunostimulator to increase the level of immunoglobulins (IgA, IgM, IgG) and subpopulations of T-lymphocytes (CD3 +, CD4 +). Also, the use of the drug has shown its usefulness in the appointment of antibacterial drugs in the treatment of upper respiratory tract infectious diseases. This article also provides an overview of recent clinical studies of drug. Researchers from various countries have tried to better clarify and define the mechanisms of action of immunostimulator both in vitro and in vivo. Of course, the improvement in research methodology over the past 20 years, and the acquired knowledge in various areas of clinical immunology, should become the starting point for further research on the drug. Randomized controlled trials of the trial use of the drug in the prevention of acute respiratory infections.

  • The use of modified autografts for plastic closure of laryngotracheal defects: an experimental study

    by V.M. Svistushkin Svistushkin, S.V. Starostina Starostina, L.V. Selezneva Selezneva, O.I. Baum Baum, E.N. Sobol Sobol, Yu.M. Aleksandrovskaya Aleksandrovskaya, A.V. Starostin Starostin


  • Mechanisms of laser activation of chondrocytes in osteoarthritis healing

    by Yu M Alexandrovskaya, O I Baum, A B Shekhter, E V Petersen, O A Tiflova, A K Dmitriev, V A Ulyanov, V M Svistushkin, L V Selezneva, E N Sobol

    Lasers offer new possibilities in the treatment of such widespread diseases as osteoarthritis, with both direct and indirect effects on cell metabolism. Cyclic hydrostatic pressure is one of the main natural stimuli of cartilage chondrocytes. The present work shows that hydrostatic stimulation with magnitudes of up to 20 MPa can be realized locally through infrared impact on the neighboring media of chondrocytes. We compare indirect (thermomechanical, λ = 1560 nm) and direct (photo-modulation, λ 1 = 1560 nm, λ 2 = 670 nm) laser effects on the synthetic activity of chondrocytes in cultures within a 1 min exposure time limit, to study separately the photo-modulation and thermomechanical components of laser impact. The chondrocyte activity was monitored by immunohistochemical analysis in normoxic and hypoxic conditions. Collagen II and proteoglycan accumulation increased significantly (up to 70%) after a pulsed thermomechanical laser impact. Thermomechanical laser irradiation showed the more pronounced stimulation in both normoxic and hypoxic conditions, while the effect of photo-modulation was inhibited by oxygen concentration increase. Theoretical calculations of the laser-induced temperature and stress fields show that the spreading of the stress field with a maximum at 19.2 MPa is approximately three times greater than that of appreciable (>1 °C) heating. Thus, thermomechanical infrared stimulation of chondrocytes can be a perspective method for the restoration of hyaline-type cartilage.